Latent Transforming Growth Factor β Binding Protein 2 (LTBP2) as a Novel Biomarker for the Diagnosis and Prognosis of Pancreatic Carcinoma

BACKGROUND: Latent transforming growth factor β binding protein 2 (LTBP2) is proven to be associated with ECM and involved in the advancement of several kinds of cancer. The present study evaluated the diagnosis and prognosis of pancreatic carcinoma (PC) using LTBP2 as a biomarker. MATERIAL/METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cheng, Wang, Gang, Zhang, Lu, Pan, Jingen, Wei, Yajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507795/
https://www.ncbi.nlm.nih.gov/pubmed/28669978
http://dx.doi.org/10.12659/MSM.905284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507795/
https://www.ncbi.nlm.nih.gov/pubmed/28669978
http://dx.doi.org/10.12659/MSM.905284

Ejemplares similares